Dr. John Luther Boone, M.D. Otolaryngology - Otolaryngology/Facial Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 14020 Hwy 13 S Ste 350, Savage, MN 55378 Phone: 952-395-2500 |
News Archive
Although newborn babies in rich countries routinely have their hearing tested, the major global health agencies, such as the World Bank and Unicef, have not prioritized funding for newborn hearing tests in poor countries, writes Dr Bolajoko Olusanya (University of Lagos, Nigeria and University College London, UK) in PLoS Medicine.
Think back to your last fight with someone you love. How did you feel afterwards? How did you behave? Conflict with a loved one often leaves a person feeling terrible and then behaving badly. So much so that these scenarios have become soap opera clich-s. After an argument, one partner may brood, slam the door, and then drive to a local bar to drown their sorrows in alcohol. These dramas rarely have happy endings. Given these stereotypes, how do people control their emotional reactions and prevent emotional storms and their attendant use of intoxicating substances?
During the 12 months after undergoing noncardiac surgery, patients with or at risk for heart disease who were treated with the beta blocker metoprolol for 30 days were less likely than patients who received a placebo to have a heart attack, but more likely to die or have a stroke, according to research presented at the American College of Cardiology's 67th Annual Scientific Session.
BC Platforms, a world leader in genomic data management and analysis solutions, today announces it has launched BC|RQUEST, a unique resource that enables integrated analytics of genomic and clinical data.
Researchers at Spectrum Health Helen DeVos Children's Hospital have completed the first clinical trial of a new treatment for children suffering from neuroblastoma. In a clinical trial led by Giselle Sholler, MD, pediatric oncologist at Helen DeVos Children's Hospital and the Neuroblastoma and Medulloblastoma Translational Research Consortium (NMTRC), DFMO, an investigational agent, showed minimal side effects with long-term survival of three patients.
› Verified 9 days ago